Rhelion Life Sciences' subsidiary Filament Health has signed an agreement to supply PEX010 psilocybin capsules and matching placebos for a clinical study by the Centre for Human Drug Research in the Netherlands. The study focuses on low and medium doses of psilocybin and is supported by Leiden University and Norrsken Mind. Filament will also provide regulatory support for the trial application under EU regulations. This collaboration highlights Filament's role as a key supplier of pharmaceutical-grade natural psilocybin for global research.
Rhelion Life Sciences' subsidiary Filament Health is the subject of this update. For readers following the Health sector, here is Pluang's market snapshot as of Sep 17, 2026 18:11 WIB: out of 91 priced US Health stocks, 63 rose and 25 fell. Notable movers include DNA (Ginkgo Bioworks Holdings Inc) at USD 7.18 with a +1.70% change, A (Agilent Technologies Inc) at USD 151.19 with a -1.63% change, and NVAX (Novavax Inc) at USD 9.50 with a +1.60% change and 100% buy order activity on Pluang.
Moving iMage Technologies, a provider of cinema technology products, will announce its Q4 fiscal 2026 financial results before the market opens on September 24, 2026. The company will host an investor call at 11:00 am ET the same day to discuss the r...
Eloro Resources Ltd. is establishing a wholly-owned subsidiary in Hong Kong called Eloro Resources (Asia) Ltd. This new entity will serve as a regional platform to support project development, concentrate sales, marketing, investor relations, and cap...
VICI Properties and Realty Income, two REITs with different portfolios, recently reported earnings highlighting a choice between higher yield and dividend stability. VICI offers a 7.19% yield with faster payout growth but has concentrated tenant risk...
Paychex reported a 12% revenue increase and 11% EPS growth in Q4 2026, supported by synergies from its Paycor acquisition and organic gains. The company also expanded its margins by 70 basis points. For fiscal year 2027, Paychex projects 5-6% revenue...
Brinker International announced its 2026 Investor Day in Dallas, revealing plans to grow revenue by 4-6% annually and open 30 new Chili's restaurants each year by fiscal 2029. The company aims to boost net income per share with double-digit growth an...
